3557 results for «2002»

Filter By

3557 results

Mitral challenges: from paravalvular leaks to valve-in-valve

12 Sep 2025 – From PCR Rio Valves 2025

Explore complex mitral valve challenges including paravalvular leaks, valve-in-valve implantation, and comprehensive percutaneous cardiac reconstructions. This session highlights innovative percutaneous solutions for surgical no-go zones, haemolytic leaks, and multi-territory device therapies to improve patient outcomes.

Clinical puzzles in structural interventions

11 Sep 2025 – From PCR Rio Valves 2025

Delve into complex clinical puzzles encountered in structural heart interventions. This session presents comparative outcomes in paradoxical low flow versus high gradient severe aortic stenosis post-TAVI, explores manual and automatic CT measurement techniques, evaluates valve-in-valve procedures within mechanical valves through meta-analysis, and discusses TAVI strategies in...

TAVI in complex anatomy: high stakes and tight spaces

12 Sep 2025 – From PCR Rio Valves 2025

Address the high-stakes challenges of TAVI in complex anatomical scenarios. This session discusses high-risk valve-in-valve interventions, management of delayed coronary obstruction, procedures in small annuli, and innovative bailout strategies including carotid TAVI.

Mitral TEER intraprocedural guidance

11 Sep 2025 – From PCR Rio Valves 2025

This session offers a detailed exploration of mitral TEER intraprocedural guidance through case-based learning. It highlights step-by-step techniques, including post-processing and key questions interventionalists face regarding residual regurgitation, clip insertion, and evaluating final procedural outcomes.

Tricuspid valve - How to evaluate?

12 Sep 2025 – From PCR Rio Valves 2025

This session offers a detailed evaluation framework for the tricuspid valve, encompassing clinical decision-making, anatomical assessment with 2D and 3D imaging, quantification of regurgitation, and differentiation of secondary and device-related tricuspid regurgitation, supported by advanced imaging software techniques.

Minimalist approach to tricuspid valve therapy

11 Sep 2025 – From PCR Rio Valves 2025

Discover the minimalist approach to tricuspid valve therapy showcased through TricValve implantation, emphasizing a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Review clinical evidence demonstrating reduced hospitalizations, improved quality of life, and favorable mid-term outcomes such as decreased right heart chamber dimensions...

TAVI outcomes in special clinical settings: cancer, diabetes, and frailty

12 Sep 2025 – From PCR Rio Valves 2025

Delve into the complexities of TAVI outcomes in special clinical populations including patients with cancer, diabetes, and frailty. This session reviews critical analyses and meta-analyses addressing ischemic cerebrovascular events post-TAVI, and compares mortality and post-procedural outcomes between diabetic and non-diabetic patients, providing valuable insights for personalized...

Alain G. Cribier

07 Nov 2017

In 2002, Alain Cribier revolutionised the field by introducing transcatheter aortic valve implantation (TAVI) as a complementary technique to surgery. Find out more about his early life and studies.

Alain G. Cribier: Legion of honour

Transcatheter aortic valve implantation (TAVI)

10 Sep 2025

Aortic stenosis (AS) is the most common valvular heart disease leading to intervention. It is characterized by progression from leaflet thickening and calcification to significant haemodynamic stenosis which results in disease-specific symptoms and physical limitations as well as poor prognosis and impaired quality of life if...

Authors :

Daijiro Tomii, Thomas Pilgrim, Jonas Lanz, Taishi Okuno, Stephan Windecker
The PCR Textbook on TAVI

Aortic stenosis prevalence and balloon aortic valvuloplasty

08 Nov 2017

The transformation in the field of interventional cardiology is unprecedented. Today, interventional cardiology encompasses an ever-growing list of diagnostic and therapeutic percutaneous procedures performed in the cathlab.

Prevalence of aortic stenosis

In remembrance of Alain Cribier

17 Feb 2024

It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...

In remembrance of Alain Cribier

PCRonline announces its new Editor-in-Chief!

14 Feb 2020

Salvatore Brugaletta is an Interventional Cardiologist at the “Hospital Clínic de Barcelona”, Spain and associate professor of Medicine at the University of Barcelona. Highly skilled in Clinical Research, Medical Education and Medical Devices with strong commitment inside medical communities, he received two PhD degrees focused on interventional cardiology from Erasmus University (Rotterdam,...

PCRonline announces its new Editor-in-Chief, Salvatore Brugaletta

30 years of primary PCI – a tale of perseverance

16 May 2023

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

30 years of primary PCI – a tale of perseverance

Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study

02 Jun 2022

Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System

15 Feb 2022

A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension

13 Nov 2024

Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
Didn’t find what you were looking for?